Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.94
Delayed Data
As of Feb 24
 -0.17 / -4.14%
Today’s Change
2.53
Today|||52-Week Range
8.10
-27.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-31.3M-36.4M-55.7M-46.9M
 
 
 
 
 
Depreciation148.0K594.0K842.0K847.0K
 
 
 
 
 
Total Other Cash Flow18.0M4.5M6.0M6.5M
 
 
 
 
 
Funds From Operations-13.2M-31.3M-48.8M-39.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.8M-3.4M-2.6M1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-11.3M-27.9M-46.2M-41.0M
 
 
 
 
 
 
InvestingIncrease In Investments-104.4M-258.3M-88.3M-161.9M
 
 
 
 
 
Decrease In Investments14.1M217.9M173.4M132.0M
 
 
 
 
 
Capital Expenditures-1.7M-2.2M-266.0K-355.0K
 
 
 
 
 
Net Cash Flow Investing-92.0M-42.6M84.8M-30.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale94.9M71.4M1.4M65.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing94.9M71.4M1.4M65.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-8.4M945.0K40.1M-5.9M